Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection - Related Studies

Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus Infection

This study has been completed.

Study NCT00004644. Last updated on June 23, 2005. Information provided by Office of Rare Diseases (ORD)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Herpes Simplex

2	More general conditions related to this trial
		DNA Virus Infections
		Herpesviridae Infections
		Skin Diseases
		Skin Diseases, Infectious
		Skin Diseases, Viral
		Virus Diseases

3	Interventions listed in this trial
		acyclovir

4	More general drug interventions related to this trial
		Anti-Infective Agents
		Antiviral Agents
		Pharmacologic Actions
		Therapeutic Uses

5	Sponsors listed in this trial
		National Center for Research Resources (NCRR)
		National Institute of Allergy and Infectious Diseases (NIAID)